Table 2.
1. | How can we optimise information giving for those at risk of or affected by pregnancy hypertension? |
2. | How can pregnancy hypertension (including pre-eclampsia) be prevented in a subsequent pregnancy? |
3. | What is the cause of pregnancy hypertension (including pre-eclampsia)? |
4. | What can be done prior to pregnancy to reduce the risk of pregnancy hypertension? |
5. | What is the best way to manage pre-eclampsia? |
6. | How can we provide better support for women with pregnancy hypertension and their families? |
7. | What is the best way to diagnose pre-eclampsia promptly? |
8. | What is the effectiveness and safety of antihypertensive agents at reducing blood pressure in women with pregnancy hypertension? |
9. | What are the long-term consequences of pre-eclampsia for the woman and baby? |
10. | What is the effectiveness and safety of pharmacological treatments once pre-eclampsia is diagnosed? |
11. | How does the placenta contribute to pre-eclampsia? |
12. | What is the optimal antihypertensive medication to use postnatally? |
13. | What is the best screening test for pre-eclampsia? |
14. | What are the optimum blood pressure thresholds (for initiation) and targets for antenatal antihypertensive treatment? |
15. | Is there a hereditary link in pre-eclampsia and are the risks different for daughters and sons after an affected pregnancy? |
16. | How can we predict complications of pregnancy hypertension (progression to pre-eclampsia)? |
17. | What is the optimal timing of delivery in women with pregnancy hypertension? |
18. | What interventions are effective and safe at reducing fetal growth restriction in women with pregnancy hypertension? |
19. | What are the long-term effects of pre-eclampsia on mental health? |
20. | Following pregnancy hypertension, what is the best way to prevent future long-term problems? |
21. | What are the educational needs of healthcare professionals managing women with pregnancy hypertension? |
22. | What are the fetal, infant and child outcomes in women taking antihypertensive agents? |
23. | How can we better prevent stillbirth in pre-eclampsia? |
24. | What are the optimum blood pressure thresholds (for initiation) and targets for postnatal antihypertensive treatment? |
25. | What prepregnancy management of women with chronic hypertension optimises pregnancy outcomes? |
26. | What is the optimal monitoring strategy for women before, during and after pregnancy hypertension (including in subsequent pregnancies)? |
27. | What are the risk factors for developing pregnancy hypertension and pre-eclampsia? |
28. | How can pregnancy hypertension (including pre-eclampsia) be prevented during a pregnancy? |
29. | What is the risk of pregnancy hypertension in a subsequent pregnancy? |
30. | What is the best test to predict pregnancy hypertension? |
31. | What methods are effective at measuring blood pressure in women with pregnancy hypertension (including self-monitoring, ambulatory, automated, manual)? |
32. | What is the paternal contribution to pre-eclampsia? |
33. | What are the characteristics of postpartum pre-eclampsia? |
34. | What is the safety of treatments for pregnancy hypertension for the fetus and infant? |
35. | What are the long-term effects of pre-eclampsia on cardiovascular disease for the woman and baby? |
36. | What are the long-term effects of pregnancy hypertension on subsequent maternal blood pressure? |
37. | What are the consequences of pregnancy hypertension on pre-eclampsia, birth weight and prematurity in that pregnancy? |
38. | What is the relationship between blood pressure in pregnancy and development of pregnancy hypertension? |
39. | What are the mechanisms for increased cardiovascular risk for a woman and her child? |
40. | What are the effects of lifestyle interventions (eg, diet, exercise) in reducing high blood pressure in pregnancy? |
41. | What are the short-term and long-term health implications for infants of women with pregnancy hypertension and can these be modified? |
42. | What are the long-term neurodevelopmental implications of pregnancy hypertension for the child? |
43. | How does pregnancy hypertension affect the growth of the baby? |
44. | What is the best way to follow up women who experience pregnancy hypertension? |
45. | Do pregnancy characteristics predict infant and child morbidity? |
46. | What is the effectiveness and safety of aspirin for prevention of pre-eclampsia? |
47. | What are the links between maternal emotional well-being and pregnancy hypertension? |
48. | What non-pharmacological treatments are effective in treating high blood pressure following pregnancy hypertension? |
49. | How do sleep disorders affect pregnancy hypertension? |
50. | What are patient-reported outcomes of interest related to hypertension in pregnancy? |
The first 25 listed above were highly ranked in the survey and therefore brought forward to the final prioritisation workshop.